2003 News

Leslie Z. Benet Named Thomson ISI Highly Cited Researcher

Leslie Z. Benet, PhD, was named a Thomson ISI Highly Cited Researcher in December 2003. The designation means that Benet's research publications on pharmacokinetics and pharmacodynamics have been extensively cited by other scientists in their publications. Citation is an important way to measure influence in science through time.

R. William Soller Appointed as Executive Director for Consumer Self Care Center

R. William Soller, PhD is the new director of the Center for Consumer Self Care, UCSF School of Pharmacy. The Center supports research on consumer behavior and health policy issues related to prescription and non-prescription medicines and dietary supplements.

Is California Prepared for a Public Health Emergency?

California Poison Control System and Statewide Area Health Education Center Program Accept Disaster Preparedness Role

Hinds Establish Pharmacy's First Distinguished Professorship

The UCSF School of Pharmacy will establish its first distinguished professorship following a gift from one of its most illustrious alums. Harry Wm. Hind -- inventor of both the Lidoderm® patch and the wetting solution that helped bring contact lenses into widespread use -- and his wife, Diana V.

Update from the Dean - July 2003

Reactions to Mission Bay moves. Ideas for generating revenue to offset the California budget deficit. How we gather input and advice to shape our planning. Awards and retirements (Kuntz, McCart, Ruggiero, Sutherland). Relocation of the Office of Student & Curricular Affairs. New School of Medicine Dean David Kessler, MD. Harry W. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences.

Kuntz Receives Volwiler Award

Irwin (Tack) D. Kuntz, PhD, professor, Department of Pharmaceutical Chemistry, UCSF School of Pharmacy has been named the 2003 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP).

WHO Plan for Global Tobacco Control Contested by US

A plan seeded in 1996 by the World Health Organization for an international agreement, [Framework Convention on Tobacco Control] [link defunct]," is undergoing final discussions by member states before submission to the World Health Assembly in May. The plan outlines a global regulatory system aimed at controlling the tobacco pandemic, which, if no action is taken, is expected to claim an estimated 10 million lives by the late 2020s.

Ban Voted on Tobacco Industry Funds

UCSF faculty members voted last December 52% to 48% to no longer accept funds from manufacturers of tobacco products or their subsidiaries. Those in favor of the ban argued that UCSF must oppose tobacco industry funding of academia since the health sciences campus is a leader in tobacco control policies and the fight against nicotine addiction and tobacco use prevention.

Update from the Dean - February 2003

California budget defecit leads to UC cuts and student fee increases. Scientists move in to Mission Bay. 2003 PharmD applications up 32% over 2002. ACPE Accreditation approved. Exit survey and post-graduate survey results. Honors and awards (The Annals of Pharmacotherapy, Kuntz, Pohorille, Nguyen, Whitely).

RNA Model Studies Could Lead to Drugs that Halt HIV Replication

Tom James, PhD, chair of the department of pharmaceutical chemistry, UCSF School of Pharmacy, is looking for new drug models that act directly on RNA rather than protein, where most drug work is now being done. Why?

Tobacco Industry Cover-up of 1981 Passive Smoke Study Revealed

The tobacco industry was the silent partner behind a study to refute an influential 1981 Japanese research study about the harmful effects of passive smoke, according to UCSF School of Pharmacy tobacco policy scientist Lisa Bero, PhD and her colleague Mi-Kyung Hong, MPH. For more information, see "